Clinical Trial Results: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results of a precision medicine approach (SMMART-ACT) in patients with advanced sarcoma, breast, ovarian, pancreatic, or prostate cancer; trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Malignant Solid Neoplasm
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Sarcoma

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2026-04-28